CYBN
Price
$8.15
Change
-$0.43 (-5.01%)
Updated
Jun 27 closing price
Capitalization
173.36M
EYPT
Price
$9.64
Change
-$0.73 (-7.04%)
Updated
Jun 27 closing price
Capitalization
663.35M
30 days until earnings call
Interact to see
Advertisement

CYBN vs EYPT

Header iconCYBN vs EYPT Comparison
Open Charts CYBN vs EYPTBanner chart's image
Cybin
Price$8.15
Change-$0.43 (-5.01%)
Volume$184.17K
Capitalization173.36M
EyePoint Pharmaceuticals
Price$9.64
Change-$0.73 (-7.04%)
Volume$1.83M
Capitalization663.35M
CYBN vs EYPT Comparison Chart in %
Loading...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYBN vs. EYPT commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYBN is a Buy and EYPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CYBN: $8.15 vs. EYPT: $9.64)
Brand notoriety: CYBN and EYPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYBN: 64% vs. EYPT: 220%
Market capitalization -- CYBN: $173.36M vs. EYPT: $663.35M
CYBN [@Biotechnology] is valued at $173.36M. EYPT’s [@Biotechnology] market capitalization is $663.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYBN’s FA Score shows that 1 FA rating(s) are green whileEYPT’s FA Score has 1 green FA rating(s).

  • CYBN’s FA Score: 1 green, 4 red.
  • EYPT’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than CYBN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYBN’s TA Score shows that 3 TA indicator(s) are bullish while EYPT’s TA Score has 6 bullish TA indicator(s).

  • CYBN’s TA Score: 3 bullish, 5 bearish.
  • EYPT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than CYBN.

Price Growth

CYBN (@Biotechnology) experienced а +4.76% price change this week, while EYPT (@Biotechnology) price change was +14.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($663M) has a higher market cap than CYBN($173M). EYPT YTD gains are higher at: 29.396 vs. CYBN (-7.596). CYBN has higher annual earnings (EBITDA): -134.52M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. CYBN (136M). CYBN has less debt than EYPT: CYBN (0) vs EYPT (24.1M). EYPT has higher revenues than CYBN: EYPT (56M) vs CYBN (0).
CYBNEYPTCYBN / EYPT
Capitalization173M663M26%
EBITDA-134.52M-144.55M93%
Gain YTD-7.59629.396-26%
P/E RatioN/AN/A-
Revenue056M-
Total Cash136M318M43%
Total Debt024.1M-
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
17
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYBNEYPT
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JMPLY47.96N/A
N/A
Johnson Matthey plc
QIFTF0.58N/A
N/A
Quorum Information Technologies Inc.
ROIUF0.07N/A
N/A
Route1 Inc.
PLRRF5.98N/A
N/A
Polar Capital Holdings PLC
CRHKY6.33-0.06
-0.94%
China Resources Beer Holdings Company Limited

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
-5.01%
ATAI - CYBN
46%
Loosely correlated
-2.22%
ABSI - CYBN
39%
Loosely correlated
-3.32%
RXRX - CYBN
39%
Loosely correlated
-6.85%
ABCL - CYBN
39%
Loosely correlated
-3.48%
EYPT - CYBN
35%
Loosely correlated
-7.04%
More

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
-7.04%
OCUL - EYPT
64%
Loosely correlated
-2.54%
LYRA - EYPT
58%
Loosely correlated
-31.91%
BEAM - EYPT
57%
Loosely correlated
-1.98%
CRSP - EYPT
54%
Loosely correlated
N/A
ATHE - EYPT
54%
Loosely correlated
+0.34%
More